Jelena Bila

Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study

2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové

Publication